drugset / Trial / NCT02737826

Discontinuation From Chronic Opioid Therapy For Pain Using a Buprenorphine Taper

NCT02737826

Completed 32 enrolled Medical University of South Carolina
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Chronic opioid therapy for pain can be associated with significant risks, and a significant number of patients maintained on chronic opioids have continued pain and/or poor functioning. When patients need to or want to come off their opioid pain medications, there is little to guide physicians as to how to best help them do so, and it is not known how patients do after coming off opioid medications. The goals of this study are (1) to evaluate two medications in assisting patients in coming off their opioid pain medications and (2) determining outcomes after discontinuing opioids.

Timeline

Start
2016-05
Primary completion
2019-12-09
Completion
2021-01-13

Drugs

EvaluationDrugModalityDoseRoute
Subject Buprenorphine Other / unclassified 24 mg Other
Comparator Gabapentin Small molecule 1600 mg Oral

Indications